A Bayesian meta-analysis of the effects of administering an intra-vaginal (CIDR) device in combination with other hormones on the reproductive performance of cycling, anoestrous and inseminated cows

Hormone use for reproductive diseases and heat induction in relation to herd-level reproductive performance in Dutch dairy farms

This ecological study aimed to associate hormone use for reproductive diseases and heat induction with reproductive performance at herd level. Hormone use, herd characteristics, and test-day recording data were obtained from 754 representative Dutch dairy farms belonging to five large veterinary practices from 2017 to 2019 (1679 observations in total). Hormone use was classified into prostaglandin, gonadotropin-releasing hormone (GnRH), and progesterone, and was expressed at herd level as the annual number of hormone doses per 100 adult dairy cows. Hormone use was categorized into four levels (no usage, low, medium, and high use), following the 33rd and 66th percentiles of herds that applied them. Three herd-level reproductive performance indicators (calving interval, calving-to-1st insemination interval, number of inseminations per cow) were analyzed using multivariable General Estimating Equations models. The median annual total hormone use was 36.1 (mean=43.1; min=0.0; max=248.2) doses per 100 adult dairy cows in all herds while the median was 39.2 (mean=46.8; min=0.4; max=248.2) doses per 100 adult dairy cows among the user-herds. The median annual group-specific hormone use was 21.3 (mean=26.1; min 0.0; max=180.0), 11.0 (mean=15.3; min=0.0; max=127.0) and 0.0 (mean=1.8; min=0.0; max=40.3) doses per 100 adult dairy cows for prostaglandin, GnRH, and progesterone, respectively. The final statistical models identified that herds with a high hormone use had a calving interval and a calving-to-1st insemination interval that was 9.3 ± 2.6 and 16.4 ± 2.1 days shorter than that of non-user herds (424.0 ± 2.7 and 114.0 ± 2.1 days), respectively. Furthermore, high-user herds needed on average 0.3 ± 0.04 inseminations more to get their cows pregnant compared to non-user herds (1.83 ± 0.04 no. of inseminations per cow). Medium-user herds had a 6.5 ± 2.6 days shorter calving interval and a 12.0 ± 2.1 days shorter calving-to-1st insemination interval with 0.2 ± 0.04 additional inseminations per cow compared to non-user herds. Low-user herds had a 6.2 ± 2.7 days shorter calving interval and a 7.9 ± 2.2 days shorter calving-to-1st insemination interval compared to non-user herds. The model produced the same trend for prostaglandin and GnRH use, with the higher use being associated with a shorter calving interval, a shorter calving-to-1st insemination interval, and a higher insemination per cow number. For progesterone use the opposite effect was observed. In conclusion, using a large representative herd-level dataset, hormone use was associated with a better reproductive performance in terms of calving interval and calving-to-1st insemination interval but gave extra average number of inseminations per cow. It should be monitored how reproduction performance changes when striving for a more prudent hormone use.

Synchronization and resynchronization of inseminations in lactating dairy cows with the CIDR insert and the Ovsynch protocol

Pregnancy per artificial insemination (AI) was evaluated in dairy cows (Bos taurus) subjected to synchronization and resynchronization for timed AI (TAI). Cows (n=718) received prostaglandin F(2alpha) (PGF) on Days -38 and -24 (Days 39 and 53 postpartum), gonadotropin-releasing hormone (GnRH) on Day -10, PGF on Day -3, and GnRH and TAI on Day 0. Between Days -10 and -3, cows received a progesterone intravaginal insert (CIDR group) or no CIDR (Control group). Between Days 14 and 23, cows received a CIDR (Resynch CIDR group) or no CIDR (Resynch control group), GnRH on Day 23, with pregnancy diagnosis on Day 30. Cows in estrus (between Days 0 and 30) were re-inseminated at detected estrus (RIDE). Nonpregnant cows received PGF on Day 30 and GnRH and TAI on Day 33. Plasma progesterone was determined to be low or high on Days -24 and -10. Pregnancy rates were evaluated 30 and 55 d after AI. The CIDR insert included in the Presynch-Ovsynch protocol did not increase overall pregnancy per AI for first service (36.1% and 33.6% for CIDR; 34.1% and 28.8% for Control) but did decrease pregnancy loss (7.0% for CIDR and 15.6% for Control). The CIDR insert increased pregnancy per AI in cows with high progesterone at the time the CIDR insert was applied. Administration of a CIDR insert between Days 14 and 23 of the estrous cycle after first service did not increase overall pregnancy per AI to second service (24.7% and 22.7% for Resynch CIDR; 28.6% and 25.3% for Resynch control). For second service, RIDE cows had lower pregnancy rates in the Resynch CIDR group than in the Resynch control group. Cows with a CL (corpus luteum) at Day 30 had higher pregnancy rates in the Resynch CIDR group than those in the Resynch control group.

Assessment of the effects of supplementation with vitamin E on health and production of feedlot cattle using meta-analysis

Delivery of supplemental antioxidant vitamins to cattle placed in feedlots might be expected to improve health and performance outcomes by reducing the effects of oxidative stress to which these cattle are presumably exposed. Meta-analytic procedures were used in this study to assess published experiments on the effects of vitamin E supplementation in feedlot cattle. The health outcome of morbidity, and the production outcomes of average daily gain (ADG) and gain to feed ratio (G:F), were analysed. The currently available data do not support the use of supplemental vitamin E administered as an injection (morbidity risk ratio=1.17; P=0.17). The authors conclude that supplemental dietary vitamin E should be fed within the [NRC, 1996. National Research Council. Nutrient Requirements of Beef Cattle, 7th ed. Natl. Acad. Press, Washington, DC] recommended range.